Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association studyCyril Pottier|The Lancet Neurology|2018Cited by 127
<i>APOE</i> *4 risk‐modifying genes and drug targets in Alzheimer's disease through cell‐type‐specific genomic analysesYoujie Zeng, Michaël E. Belloy, Chenyu Yang et al.|Alzheimer s & Dementia|2026Cited by 1